Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes

Journal of Biomedical Science

Volumn 5, Issue 1, 1998, Pages 31-44

  Krebs, Fred C ^a   Mehrens, Dorothy ^a   Pomeroy, Steven ^b   Goodenow, Maureen M ^b   Wigdahl, Brian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Astrocyte; cAMP response element; HIV 1; Long terminal repeat; Lymphocyte; Quasispecies

Indexed keywords

NUCLEAR FACTOR;

ARTICLE; GENETIC VARIABILITY; GLIA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE MIGRATION; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031898668     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253354     Document Type: Article

References (38)

1. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573-585;1996.
2. Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny A, Muller-Lantzsch N, Stavrou D, Erfle V. Infection of human brain cells by HIV-1: Restricted virus production in chronically infected human glial cell lines. AIDS 6:273-285;1992.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254;1976.
4. Cullen BR. Regulation of human immunodeficiency virus replication. Annu Rev Microbiol 45:219-250;1991.
5. Dewhurst S, Bresser J, Stevenson M, Sakai K, Evinger-Hodges MJ, Volsky DJ. Susceptibility of human glial cells lo infection with human immunodeficiency virus (HIV). FEBS Lett 213:138-143;1987.
6. Digman JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489;1983.
7. Eilbott DJ, Peress N, Burger H, LaNeve D, Orenstein J, Gendelman HE, Seidman R, Weiser B. Human immunodeficiency virus type I in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc Natl Acad Sci USA 86:3337-3341;1989.
8. England G, Hoggan MD, Theodore TS, Martin MA. A novel HIV-1 isolate containing alterations affecting the NF-kappa B element. Virology 181:150-157;1991.
9. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 70:4052-4062;1996.
10. Feuerstein N, Firestein R, Aiyar N, He X, Murasko D, Cristofalo V. Late induction of CREB/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor. J Immunol 156:4582-4593;1996.
11. Garner MM, Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: Application to components of the Escherichia coil lactose operon regulatory system. Nucleic Acids Res 9:3047-3060;1981
12. Golub EI, Li GG, Volsky DJ. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol 64:3654-3660;1990.
13. Goodenow MM, Hiet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr Hum Retrovirol 2:344-352;1989.
14. Jones KA, Peterlin BM. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717-743;1994.
15. Katz RA, Skalka AM. Generation of diversity in retroviruses. Annu Rev Genet 24:409-445;1990.
16. Kingman SM, Kingman AJ. The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem 240:491-507;1996.
17. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093;1986.
18. Krebs FC, Goodenow MM, Wigdahl B. Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. J NeuroVirol 3, Suppl. 1:S28-S32;1997.
19. Lamers SL, Sleasman JW, She JX, Barrie KA, Pomeroy SM, Barrett DJ, Goodenow MM. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J Clin Invest 93:380-390;1994.
20. McMillian MK, Thai L, Hong JS, O'Callaghan JP, Penny-packer KR. Brain injury in a dish: A model for reactive gliosis. Trends Neurosci 17:138-142;1994.
21. McNearney T, Hornickova Z, Templeton A, Birdwell A, Arens M, Markham R, Saah A, Ratner L. Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. Virology 208:388-398;1995.
22. Michael NL, D'Arcv L, Ehrenberg PK, Redfield RR. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and tat-induced transcriptional activities. J Virol 68:3163-3174;1994.
23. Myers G, Foley B, Mellors JW, Korber B, Wain-Hobson S, Jeang K-T, eds. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic and amino acid sequences. Los Alamos, NM, Los Alamos National Laboratory, 1996.
24. Neumann M, Felber BK, Kleinschmidt A, Froese B, Erfle V, Pavlakis GN, Brack-Werner R. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 69:2159-2167;1995.
25. Niikura M, Dornadula G, Zhang H, Mukhtar M, Lingxun D, Khalili K, Bagasra O, Pomerantz RJ. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell. Oncogene 13:313-322;1996.
26. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor alpha RNA in the central nervous system. Am J Pathol 144:659-666;1994.
27. Pennypacker KR, Hong JS, Mullis SB, Hudson PM, McMillian MK. Transcription factors in primary glial cultures: Changes with neuronal interactions. Brain Res Mol Brain Res 37:224-230;1996.
28. Price RW. Understanding the AIDS dementia complex (ADC): The challenge of HIV and its effects on the central nervous system. In: Price RW, Perry SW III, eds. HIV. AIDS, and the Brain. New York, Raven Press, 1-45:1994.
29. Purschke WG, Muller PK. An improved fluor diffusion assay for chloramphenicol acetyltransferase gene expression. Biotechniques 16:264-269;1994.
30. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9:1001-1008;1995.
31. Shahabuddin M, Volsky B, Kim H, Sakai K, Volsky DJ. Regulated expression of human immunodeficiency virus type 1 in human glial cells: Induction of dormant virus. Pathobiology 60:195-205;1992.
32. Taylor JP, Pomerantz RJ, Raj GV, Kashanchi F, Brady JN, Amini S, Khalili K. Central nervous system-derived cells express a κB-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J Virol 68:3971-3981;1994.
33. Tong-Starkesen SE, Luciw PA, Peterlin BM. Signaling through T lymphocyte surface proteins. TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 142:702-707;1989.
34. Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65:6094-6100;1991.
35. Tornatore C, Chandra R, Berger JR, Major EO HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487;1994.
36. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093;1986.
37. Wiley CA, Nelson JA. Human immunodeficiency virus: Infection of the nervous system. Curr Top Microbiol Immunol 160:157-172;1990.
38. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC. Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 231:850-853;1986.